Literature DB >> 21761317

Neuronal type-specific gene expression profiling and laser-capture microdissection.

Charmaine Y Pietersen1, Maribel P Lim, Laurel Macey, Tsung-Ung W Woo, Kai C Sonntag.   

Abstract

The human brain is an exceptionally heterogeneous structure. In order to gain insight into the neurobiological basis of neural circuit disturbances in various neurologic or psychiatric diseases, it is often important to define the molecular cascades that are associated with these disturbances in a neuronal type-specific manner. This can be achieved by the use of laser microdissection, in combination with molecular techniques such as gene expression profiling. To identify neurons in human postmortem brain tissue, one can use the inherent properties of the neuron, such as pigmentation and morphology or its structural composition through immunohistochemistry (IHC). Here, we describe the isolation of homogeneous neuronal cells and high-quality RNA from human postmortem brain material using a combination of rapid IHC, Nissl staining, or simple morphology with Laser-Capture Microdissection (LCM) or Laser Microdissection (LMD).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21761317      PMCID: PMC4410965          DOI: 10.1007/978-1-61779-163-5_28

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  11 in total

Review 1.  Expression profiling using human tissues in combination with RNA amplification and microarray analysis: assessment of Langerhans cell histiocytosis.

Authors:  K L McClain; Y-H Cai; J Hicks; L E Peterson; X-T Yan; S Che; S D Ginsberg
Journal:  Amino Acids       Date:  2005-03-30       Impact factor: 3.520

2.  Laser capture microdissection.

Authors:  L Charboneau; C P Paweletz; L A Liotta
Journal:  Curr Protoc Cell Biol       Date:  2001-05

Review 3.  Thinking about RNA? MicroRNAs in the brain.

Authors:  Christian Barbato; Corinna Giorgi; Caterina Catalanotto; Carlo Cogoni
Journal:  Mamm Genome       Date:  2008-08-01       Impact factor: 2.957

Review 4.  Fine-tuning neural gene expression with microRNAs.

Authors:  Gerhard Schratt
Journal:  Curr Opin Neurobiol       Date:  2009-06-17       Impact factor: 6.627

Review 5.  MicroRNAs and deregulated gene expression networks in neurodegeneration.

Authors:  Kai-Christian Sonntag
Journal:  Brain Res       Date:  2010-04-07       Impact factor: 3.252

6.  Laser capture microdissection of mammalian tissue.

Authors:  Robert A Edwards
Journal:  J Vis Exp       Date:  2007-10-01       Impact factor: 1.355

7.  Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology.

Authors:  Filip Simunovic; Ming Yi; Yulei Wang; Laurel Macey; Lauren T Brown; Anna M Krichevsky; Susan L Andersen; Robert M Stephens; Francine M Benes; Kai C Sonntag
Journal:  Brain       Date:  2008-12-03       Impact factor: 13.501

8.  Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars.

Authors:  Francine M Benes; Benjamin Lim; David Matzilevich; John P Walsh; Sivan Subburaju; Martin Minns
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-06       Impact factor: 11.205

9.  Obtaining high quality RNA from single cell populations in human postmortem brain tissue.

Authors:  Charmaine Y Pietersen; Maribel P Lim; Tsung-Ung W Woo
Journal:  J Vis Exp       Date:  2009-08-06       Impact factor: 1.355

Review 10.  MicroRNAs: target recognition and regulatory functions.

Authors:  David P Bartel
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

View more
  18 in total

Review 1.  MicroRNAs in neurodegenerative diseases and their therapeutic potential.

Authors:  Eunsung Junn; M Maral Mouradian
Journal:  Pharmacol Ther       Date:  2011-10-08       Impact factor: 12.310

2.  Midbrain dopamine neurons in Parkinson's disease exhibit a dysregulated miRNA and target-gene network.

Authors:  Christine E Briggs; Yulei Wang; Benjamin Kong; Tsung-Ung W Woo; Lakshmanan K Iyer; Kai C Sonntag
Journal:  Brain Res       Date:  2015-06-03       Impact factor: 3.252

Review 3.  Recent advances in quantitative neuroproteomics.

Authors:  George E Craft; Anshu Chen; Angus C Nairn
Journal:  Methods       Date:  2013-04-25       Impact factor: 3.608

Review 4.  The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies.

Authors:  Wei Hu; Matthew L MacDonald; Daniel E Elswick; Robert A Sweet
Journal:  Ann N Y Acad Sci       Date:  2014-10-14       Impact factor: 5.691

Review 5.  Environmental stressors and epigenetic control of the hypothalamic-pituitary-adrenal axis.

Authors:  Richard S Lee; Akira Sawa
Journal:  Neuroendocrinology       Date:  2014-11-18       Impact factor: 4.914

6.  miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling.

Authors:  Woori Kim; Yenarae Lee; Noah D McKenna; Ming Yi; Filip Simunovic; Yulei Wang; Benjamin Kong; Robert J Rooney; Hyemyung Seo; Robert M Stephens; Kai C Sonntag
Journal:  Neurobiol Aging       Date:  2014-01-24       Impact factor: 4.673

7.  Physical activity correlates with glutamate receptor gene expression in spinally-projecting RVLM neurons: a laser capture microdissection study.

Authors:  Madhan Subramanian; Avril G Holt; Patrick J Mueller
Journal:  Brain Res       Date:  2014-08-28       Impact factor: 3.252

8.  Limited predictability of postmortem human brain tissue quality by RNA integrity numbers.

Authors:  Kai-C Sonntag; George Tejada; Sivan Subburaju; Sabina Berretta; Francine M Benes; Tsung-Ung W Woo
Journal:  J Neurochem       Date:  2016-05-12       Impact factor: 5.372

9.  Transcriptional regulation by nicotine in dopaminergic neurons.

Authors:  Beverley M Henley; Brian A Williams; Rahul Srinivasan; Bruce N Cohen; Cheng Xiao; Elisha D W Mackey; Barbara J Wold; Henry A Lester
Journal:  Biochem Pharmacol       Date:  2013-08-09       Impact factor: 5.858

10.  Molecular profiles of parvalbumin-immunoreactive neurons in the superior temporal cortex in schizophrenia.

Authors:  Charmaine Y Pietersen; Sarah A Mauney; Susie S Kim; Eleonora Passeri; Maribel P Lim; Robert J Rooney; Jill M Goldstein; Tracey L Petreyshen; Larry J Seidman; Martha E Shenton; Robert W Mccarley; Kai-C Sonntag; Tsung-Ung W Woo
Journal:  J Neurogenet       Date:  2014-03-17       Impact factor: 1.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.